The Future of AI and Personalized Cancer Care:
How can patient empowerment accelerate improved cancer outcomes?
The Future of AI and Personalized Cancer Care:
How can patient empowerment accelerate improved cancer outcomes?
Thank you for your interest in our pre-ASCO Symposium content.
Opening Remarks
Dr. Maya R. Said, Founder and CEO, Outcomes4Me
Keynote Opening
Featuring: Dr. Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca
Panel 1: AI in support of delivering patient-centric, guideline-concordant cancer care
Featuring:
- Dr. Crystal Denlinger, Chief Scientific Officer, NCCN®
- Dr. V.K. Gadi, Deputy Director, University of Illinois Cancer Center
- Dr. Aradhana Ghosh, VP, Oncology Informatics, Labcorp Oncology
- Dr. Chadi Nabhan, SVP and Chairman, Caris Precision Oncology Alliance
- Kimberly Richardson, President, Black Cancer Collaborative, patient advocate & cancer survivor
- Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator)
Panel 2: The role of AI in advancing equitable clinical trial recruitment and access
Featuring:
- Suzanne Garner, Stage II breast cancer survivor & NATALEE trial participant
- Dr. Kyle Holen, SVP Head of Development, Therapeutics and Oncology, Moderna
- Dr. Steven Isakoff, Associate Director, MGH Cancer Research
- Dr. Prasanth Reddy, SVP, Global Enterprise Oncology Head, Labcorp
- Dr. Maya Said, Founder and CEO, Outcomes4Me (moderator)
Panel 3: The value of AI-powered, direct-to-patient activation in the consumer privacy era
Featuring:
- Dr. Grace Cordovano, BCPA, Founder, Enlightening Results
- Dr. Debra Friedman, Associate Director, Community Science & Health Outcomes, Vanderbilt Ingram Cancer Center
- Dr. Arun Krishna, VP Head of US Lung Cancer business, AstraZeneca
- Susan Manber, Chief Patient Officer at Publicis Health
- Brenna Fitzgerald, VP of Marketing & Communications, Outcomes4Me (moderator)
